News

Exploring Royce Small-Cap Trust's Financial Performance

Exploring Royce Small-Cap Trust's Financial Performance

Royce Small-Cap Trust Overview

Royce Small-Cap Trust is a prominent closed-end diversified management investment company with a mission focused on long-term capital growth. This esteemed fund primarily invests at least 65% of its assets in equity securities of small- and micro-cap companies, making it a significant player in the small-cap investment landscape.

Key Characteristics

Identified as the oldest and largest small-cap closed-end fund, it has built a solid reputation over the years. The fund boasts an average weekly trading volume of approximately 1,141,987 shares, indicating a robust interest from investors. Moreover, its adviser brings over 50 years of experience specializing in small- and micro-cap investments. This wealth of expertise underpins the trust's investment strategies and risk management, contributing to its enduring success.

Performance Metrics

As of late January, the net asset value (NAV) for Royce Small-Cap Trust was reported at 17.36, alongside a market price (MKT) of 16.28. Notably, the fund achieved impressive returns across various time frames. For instance, the one-month total return was 2.18% for NAV and 3.04% for MKT, showcasing its ability to adapt to market fluctuations. In terms of annual returns, the one-year return was significantly higher at 18.26% for NAV and 23.41% for MKT, evidencing the fund's strong upward trajectory.

The fund demonstrated a three-year return of 6.63% (NAV) and 5.83% (MKT), while its five-year return stood at 10.79% (NAV) and 11.67% (MKT). The ten-year returns were equally compelling with NAV at 10.14% and MKT at 10.67%. These figures exemplify the trust's consistent performance and reliability for long-term investors.

Understanding Portfolio Diagnostics

Royce Small-Cap Trust provides a well-structured portfolio aimed at optimizing performance. The average market capitalization of the securities within the portfolio is approximately $3.13 billion. Additionally, the weighted average price-to-earnings (P/E) ratio is at 17.5, indicating a carefully evaluated selection of stocks that promise growth potential. The portfolio's weighted average price-to-book (P/B) ratio stands at 2.2, further reflecting the fair valuation of the underlying investments.

As of the latest reports, the fund's net assets have exceeded $2.04 billion. Such assets allow the trust to allocate investments across a diversified platform effectively, addressing multiple captures in the small-cap sector.

Portfolio Composition Insights

The Royce Small-Cap Trust comprises a range of sectors demonstrating its extensive diversification. For example, as of late January, the top five sectors included Industrials at 22.7%, Financials at 22.4%, Information Technology at 16.6%, Health Care at 9.7%, and Consumer Discretionary at 9.1%. This strategic sector allocation showcases the fund's approach to balancing risk while pursuing growth.

Furthermore, within its prominent positions, companies like Assured Guaranty and PAR Technology reflect Royce's commitment to investing in high-potential businesses that contribute to the overall growth strategy. This carefully chosen approach to portfolio management underscores the trust's proactive stance in a rapidly changing investment environment.

Recent Developments

The recent developments surrounding Royce Small-Cap Trust are noteworthy. Not only is it listed on the New York Stock Exchange under the ticker RVT, but the daily net asset values are also accessible, facilitating transparency for potential and existing investors. The trust’s commitment to keeping investors informed reflects a strong corporate ethos emphasizing confidence and clarity.

Considerable thought goes into the decision-making processes for investors considering Royce Small-Cap Trust. Understanding the fund's goals, associated risks, and fee structures is vital for ensuring that investment choices align with individual risk tolerance and financial objectives.

Frequently Asked Questions

What is Royce Small-Cap Trust's primary investment focus?

Royce Small-Cap Trust primarily focuses on investing in equity securities of small- and micro-cap companies, aiming for long-term capital growth.

How has the fund performed in the past year?

In the past year, the fund reported an 18.26% return on NAV and a 23.41% return on MKT, demonstrating strong growth.

What sectors does the fund primarily invest in?

The fund's top sectors include Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary, showing a diverse investment approach.

Is Royce Small-Cap Trust a good investment option?

Investment suitability depends on individual financial goals and risk tolerance; historically, it has provided solid returns, appealing to long-term investors.

Where can I find daily net asset values for the fund?

Daily net asset values for Royce Small-Cap Trust can be accessed on their website and through various ticker symbol lookup services.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading

Top 5 Most Recently Viewed Articles

20th Driskell Prize Gala: Celebrating African American Art

Updated Category News Views 306

The 20th Anniversary of the Driskell Prize Gala The David C. Driskell Prize Gala, often referred to as the "Met Gala of the South," is an extraordinary annual event that grandly honors the recipient of the Driskell Prize in African American Art and Art History. This prize holds the distinguished title of being the first national award recognizing the invaluable...

Continue Reading
Smartsheet Welcomes Eva Schoenleitner as New VP of Partner

Updated Category News Views 273

Smartsheet Strengthens Leadership with New Vice President Smartsheet, a leader in enterprise-grade work management, has made a significant decision in appointing Eva Schoenleitner as their Vice President of Partner. This move highlights the company’s focus on reinforcing their partner ecosystem and driving further growth in the tech industry. Experience That Counts...

Continue Reading
Piedmont Heart Institute Achieves New Heights in Transplants

Updated Category News Views 250

Piedmont Heart Institute Sets New Transplant Record Piedmont Heart Institute recently demonstrated its commitment to advancing cardiac care by achieving a remarkable milestone. In the year 2024, the institute performed 103 heart transplants at Piedmont Atlanta Hospital, establishing a new organizational record. This significant accomplishment underscores the institute's...

Continue Reading
Arizona Metals Corp's Promising Future at Kay Mine Project

Updated Category News Views 222

Arizona Metals Corp Unveils New Mineral Resource Estimate Arizona Metals Corp (TSX: AMC, OTC: AZMCF) has made waves in the mining sector with the recent announcement of its inaugural Mineral Resource Estimate (MRE) for the Kay Mine Project. This project signifies a significant milestone for the company, highlighting its resources and potential for growth. Insights into...

Continue Reading
Leidos Holdings, Inc. Raises Quarterly Cash Dividend Announcement

Updated Category News Views 147

Leidos Holdings, Inc. Announces Increased Dividend Leidos Holdings, Inc. (NYSE: LDOS) has made an exciting announcement regarding its quarterly cash dividend. The company’s board of directors has confirmed a quarterly cash dividend of $0.43 for each outstanding share of its common stock. This marks an increase of $0.03 from the previous dividend of $0.40 per share,...

Continue Reading